Ovid Therapeutics to Present at Upcoming August Investor Conferences
Provided By GlobeNewswire
Last update: Jul 30, 2024
NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by certain epilepsies and brain conditions, today announced that management will participate in two upcoming investor conferences in August:
